查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1854766

氧气供应市场按产品类型、技术、流量、应用、最终用户和销售管道划分－2025-2032年全球预测

Oxygenator Market by Product Type, Technology, Flow Rate, Application, End User, Sales Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，氧气供应市场规模将达到 57.6 亿美元，复合年增长率为 10.91%。

关键市场统计数据
基准年 2024 25.1亿美元
预计年份：2025年 27.8亿美元
预测年份 2032 57.6亿美元
复合年增长率 (%) 10.91%

为医疗保健领导者提供基础性概述，阐述氧合器技术的临床重要性、设计演变、监管动态和策略影响。

呼吸器在现代心肺和体外循环治疗中发挥核心作用，使临床医生能够在复杂的手术和重症加护过程中管理气体交换。本文概述了这项技术的临床效用，揭示了主要设备係列背后的工程原理，并将呼吸器置于不断发展的医疗路径中，其中患者安全、处理效率和生物相容性始终是重中之重。此外，我们还概述了设备设计与手术需求之间的相互作用，阐述了材料、流体动力学和表面处理的渐进式改进如何带来临床性能的实际提升。

随着成人、儿童和新生儿护理的临床需求日益多样化，呼吸器的功能范围也不断扩展，以满足特定的血流动力学和血液管理需求。同时，监管要求和采购重点也在转变，更加重视生命週期管理、上市后监测和可验证的风险缓解措施。在此背景下，相关人员必须在运作可靠性和对各种医疗环境（从门诊中心和专科诊所到医院的高级急性心臟中心）的适应性之间取得平衡。

本节透过重点介绍影响产品开发和采用的汇聚压力（临床证据、技术创新和系统级采购的需求）为更深入的分析奠定了基础，并为后续章节奠定了基础，这些章节将探讨不断变化的格局、关税的影响、细分信息、区域动态、企业战略以及对临床和商业领导者的可操作建议。

新技术的进步、临床实践的拓展以及监管要求的提高正在重新定义呼吸器的设计采用和竞争格局。

復苏器领域正经历着变革性的转变，这主要得益于技术进步、临床通讯协定的调整以及对整合系统性能的日益重视。膜化学和纤维结构的进步提高了气体交换效率和血液相容性，而感测器整合和控制演算法的创新则实现了对流量和氧合参数更精确的管理。同时，模组化和一次性使用也成为发展趋势，使得设备生命週期决策与感染控制重点和营运成本透明度更加契合。

随着技术进步，临床实务模式也不断调整。除了传统的心臟手术外，体外循环技术的应用日益广泛，并扩展到重症加护和新生儿介入等领域。因此，设备的外形规格和性能范围正在针对更广泛的临床场景进行最佳化。采购相关人员也希望采购的设备能够易于使用、维护便利且与现有电路组件相容，这进一步强化了这一趋势。

监管和支付方环境也在影响产品蓝图。对生物相容性数据、上市后监测和人因工程的日益严格的审查，促使製造商加强对可靠证据的投入。同时，医疗器材製造商与卓越临床中心之间的策略伙伴关係正在加速迭代设计和检验，从而创造出更能反映第一线临床需求的产品。总而言之，这些变化正在重塑竞争动态，并提高了产品持续临床应用的门槛。

对近期美国关税如何重塑氧气復苏器生态系统的供应链商业策略和采购行为进行预测分析。

美国新关税的实施带来了一系列复杂的营运和战略影响，相关人员都必须预见并应对这些影响。进口关税及相关贸易政策的变化给从国际采购原材料和成品的供应商带来了上游成本压力。为此，采购团队和製造商正在重新审视筹资策略、合约条款和库存管理方法，以在不断上涨的到岸成本下维持利润率和供应的连续性。

这些贸易动态也将影响区域製造地和近岸外包的决策。能够实现关键製造流程在地化或建立国内供应伙伴关係关係的企业将增强抵御关税波动的能力，而那些继续依赖跨国供应的企业则可能面临利润率下降，并需要重新设计其商业模式。面临设备和耗材价格上涨的临床医疗机构可能会优先考虑那些能够清晰展现临床和营运价值的设备，这将促使製造商加强其证据材料和生命週期成本分析。

此外，关税可能会加速产业整合和策略调整，因为企业会评估併购、许可和合资等机会，以减轻关税的影响并扩大区域通路。重要的是，积极与经销商和企业客户沟通，重新设计商业条款、制定对冲策略并提案配套服务的供应商，将更有利于顺利度过转型期。整体而言，关税调整将促使企业重新关注供应链优化、重新评估定价策略以及提升本地营运的弹性。

透过对产品系列、控制架构、流量曲线、临床应用、最终用户和销售管道动态进行细緻的細項分析，提供可执行的设备策略。

要了解氧气復苏器市场，需要细緻关注产品、技术、流量特性、应用偏好、终端用户和销售管道行为，因为每个细分维度都会影响设计优先顺序和市场推广策略。气泡式、中空纤维式和膜式等产品分类，有助于明确临床和工程方面的权衡取舍。气泡式通常分为高效型和标准型，中空纤维式有一次性使用和可重复使用两种配置，而膜式系统则根据生物相容性问题，采用肝素涂层或非涂层表面处理。这些产品差异直接影响临床选择标准和库存策略。

技术选择进一步完善了价值提案：自动化控制系统透过电子或气动感测器提供精准控制；混合平台结合了半自动和半手动功能，实现灵活的工作流程；而手动装置在优先考虑脚部或手部操作的简单性和稳定性时仍然适用。高流量解决方案包括高效能流量和超高流量；中流量装置提供增强流量和标准流量模式；低流量装置包括微流量和迷你流量，适用于特定病患群体。

应用范围涵盖心肺体外迴圈（分为成人和儿童应用）、体外膜氧气疗法（涵盖成人和新生儿应用）以及新生儿护理（侧重于培养箱支持和转运通气），这些应用决定了临床功能集和监管方面的考虑。最终用户包括门诊诊所、医院和专科诊所，其中也包括一些更具体的机构类型，例如诊断中心和门诊诊所、心臟中心和综合医院，以及专科心臟病和呼吸诊所。此外，销售管道的动态变化——包括直销策略（包括机构销售和OEM协议）、分为全国性和区域性分销商的分销网络，以及透过公司网站和第三方销售管道的线上管道——决定了製造商如何分配资源用于客户参与、培训和售后支援。这些细分因素共同构成了对氧气復苏器市场需求驱动因素和竞争格局的多角度分析。

区域比较评估重点关注美洲、中东和非洲以及亚太地区在采用驱动因素、监管细微差别和供应链优先事项方面的差异。

每个地区的市场动态都展现出不同的需求驱动因素、法规环境和供应链考量，这些因素共同塑造了製造商和供应商的策略重点。在美洲，领先的心胸外科计画、先进的急性心臟中心以及注重临床疗效和服务可靠性的综合医院系统，对临床应用产生了影响。该地区的采购週期通常优先考虑长期服务协议以及与现有体外循环系统的互通性，这为差异化支援服务和综合培训专案创造了机会。

相较之下，欧洲、中东和非洲涵盖了广泛的监管体系和医疗服务模式，各国的报销框架、区域采购联盟以及对标准化的日益重视，都对医疗器材的选择起着决定性作用。该地区高度重视统一的安全数据、对三级医疗和社区医疗的适应性，以及能够满足从先进心臟中心到急诊护理机构等各种临床环境的可扩充性服务模式。能够展现出符合监管要求和灵活商业模式的製造商，很可能在全部区域获得广泛认可。

亚太地区正经历临床能力的快速提升、新生儿和重症患者基础设施投资的增加以及对本地製造能力的重视。临床诊疗量的不断增长，尤其是在三级医院和专科诊所，推动了对兼具成本效益和临床性能的设备的需求。因此，策略伙伴关係、在地化服务网络和有针对性的培训计划对于在这个充满活力的地区建立信任并确保设备在各种医疗服务机构中的广泛应用至关重要。

企业采取的策略行动，强调产品差异化、伙伴关係、供应链韧性和一体化服务交付，以此作为实现永续竞争优势的途径。

领先的氧气復苏器製造商之间的竞争行为受到产品创新、证据累积、监管策略和商业生态系统发展等多方面因素的共同影响。成功的公司优先考虑差异化的设备特性，例如先进的膜材料、整合感测器和控制系统，以及能够减少血液凝固和发炎反应的表面处理。他们还投资于临床伙伴关係，以提供可靠的真实世界证据和人因工程检验，从而更好地向采购相关人员展示临床效益和营运价值。

在策略层面，领导企业正努力平衡自主产品研发与选择性外部合作及授权，以加速产品上市速度，同时保护核心智慧财产权。供应链韧性是企业规划的关键组成部分，透过生产冗余、品质保证体係以及本地组装和采购，降低受贸易波动和物流中断的影响。在商业性，企业正日益从交易型销售转向长期客户关係，将设备与培训、维护和数据主导服务捆绑销售。

市场领导者也会建立符合终端用户需求的经销网络，透过与临床复杂度高的医疗机构直接合作，并与全国性或区域性分销商合作，拓展更广泛的门诊和诊所市场。线上管道则透过提高标准化耗材和一次性用品的可见度并简化订购流程，对传统管道起到补充作用。这些策略选择共同决定了企业的竞争地位，并增强了企业在各个临床和地理领域中把握机会的能力。

製造商和医疗保健提供者可采取的切实可行的策略重点，以协调产品创新、证据生成、供应链弹性以及个人化商业模式，从而实现永续推广。

为确保復苏器市场的长期成长，产业领导者应采取一系列重点行动，协调产品开发、商业策略和营运韧性。首先，应优先考虑模组化产品架构和表面处理创新，以提高生物相容性，并简化成人、儿童和新生儿临床应用。透过设计互通性和简化临床工作流程，製造商可以减少应用阻力，并增强其对医院和专科诊所的价值提案。

第二，透过有针对性的临床合作加快证据生成，这些合作不仅要展示临床结果，还要展示营运效益，例如减少电路更换次数和简化维护。这些证据对于在日益需要生命週期透明度的环境中支持采购决策至关重要。第三，透过供应商多元化、寻求关键零件的在地化生产以及建立紧急库存策略来增强供应链韧性，从而降低贸易政策变化带来的风险。

第四，透过将系统性地直接接触高风险医疗中心、拓展经销商关係以及为标准化产品开发线上管道相结合，使商业模式与终端用户偏好保持一致。最后，投资售后支援和培训项目，以减少临床医生操作差异、提高设备执行时间并建立稳固的服务关係。透过这些措施，企业可以将技术能力与持续的临床应用和商业性绩效连结起来。

我们采用透明的调查方法，结合临床医师访谈、技术文献综合和基于情境的分析，为氧气復苏提供可靠且可操作的见解。

本分析整合了第一手和第二手研究、结构化专家访谈以及对临床和监管文献的系统性回顾，旨在建立復苏器市场的全面图景。主要资讯来源包括与心胸外科、加护治疗和新生儿科医生的讨论，以了解第一线设备的性能要求、人为因素考量以及采购驱动因素。此外，还结合了对产品开发负责人、分销合作伙伴和供应链专业人员的观点，以梳理商业性需求和生产限制。

次要证据包括同行评审的临床研究、监管文件和技术白皮书，这些文件记录了医疗设备的结构、材料科学的进展以及上市后安全性。在适当情况下，我们分析了展示成功临床整合和供应商-客户合作的案例研究，以提取可藉镜的经验。在整合过程中，我们优先考虑资料来源之间的三角验证，以确保结论的稳健性，并与产业专家反覆检验研究结果，以提高解释的准确性。

分析方法包括对质性访谈进行主题编码、对设备架构和控制系统进行比较特征分析，以及基于情境的供应链和关税影响评估。我们强调假设透明、分析逻辑可重复，并在资料缺失的情况下对证据进行保守解读。这种方法论能够为临床领导者、采购团队和技术开发人员提供可靠且可操作的见解。

策略意义综合分析强调了技术卓越、证据产生和供应链韧性对于推动临床应用和实现长期价值的重要性。

总之，呼吸器技术正处于曲折点，工程技术的进步、临床应用的拓展和商业性模式的重组在此交汇，既带来了巨大的机会，也带来了严峻的挑战。呼吸器的差异化越来越依赖先进膜材料、改进的生物相容性表面处理以及更智慧的控制系统的集成，这些因素共同提升了呼吸机的临床实用性和患者安全性。同时，呼吸器的临床应用范围也不断扩大，从各年龄层的心肺体外迴圈到体外循环支持和新生儿转运，这要求呼吸器具备适应性强的外形规格和经循证医学验证的性能。

在商业性，供应链韧性和灵活的分销模式正变得与产品性能同等重要。关税主导的成本压力和对本地采购的偏好凸显了製定本地化策略和伙伴关係关係的必要性，以确保供应的连续性并保持价格竞争力。能够将强有力的临床证据与无缝支援和培训相结合的医疗服务提供者和製造商，将更有利于推动产品在各种医疗环境中的应用。

最终，氧气復苏器市场将青睐那些兼顾技术卓越性和营运实用性，并积极与临床相关人员互动的企业。那些实施技术创新、累积实证医学证据并制定稳健商业策略的公司将获得最大的长期价值，并为改善患者预后做出有意义的贡献。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 携带式体外氧合设备在紧急应变的应用日益广泛
  • 推动相关法规，以加强膜式氧合器上生物相容性涂层的强度，进而减少溶血现象。
  • 将人工智慧驱动的流量监测系统整合到体外膜氧合器中，用于预测性维护
  • 为改善新生儿心血管手术的预后，低阻力儿科氧合器的需求激增
  • 开发一种结合氧合和血液滤过功能的混合灌注平台
  • 人们对聚合物基一次性氧合器的兴趣日益浓厚，希望以此最大限度地降低感染传播风险。

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：依产品类型分類的氧气供应市场

  • 气泡
    • 高效率
    • 标准
  • 中空纤维
    • 一次性的
    • 可重复使用的
  • 电影
    • 肝素涂层
    • 未涂层

9. 按技术分類的氧气供应市场

  • 自动控制
    • 电子感测器
    • 气压感知器
  • 杂交种
    • 半自动
    • 半手动
  • 手动的
    • 脚踏式
    • 手动操作

第十章 按流量分類的氧气供应市场

  • 高流量
    • 高效能流量
    • 超高流量
  • 低流量
    • 微流控
    • 微流
  • 中等流速
    • 增强流量
    • 标准流量

第十一章 依应用分類的氧气供应市场

  • 心肺体外迴圈
    • 成人
    • 孩子们
  • 体外膜氧合器
    • 成人
    • 新生
  • 新生儿护理
    • 培养箱支援
    • 运输通气

第十二章 依最终用户分類的氧气供应市场

  • 门诊治疗中心
    • 诊断中心
    • 门诊部
  • 医院
    • 心臟中心
    • 综合医院
  • 专科诊所
    • 心臟诊所
    • 呼吸科诊所

第十三章 依销售管道分類的氧气供应市场

  • 直接地
    • 机构销售
    • OEM合约
  • 批发商
    • 全国经销商
    • 区域经销商
  • 在线的
    • 公司网站
    • 第三方平台

第十四章：各地区的氧气供应市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章：按组别分類的氧气供应市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国氧气供应市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Terumo Corporation
    • Medtronic plc
    • LivaNova PLC
    • Getinge AB
    • Fresenius SE & Co. KGaA
    • Nipro Corporation
    • Nikkiso Co., Ltd.
    • Medos Medizintechnik AG
    • Asahi Kasei Medical Co., Ltd.
    • MC3 Group, Inc.
Product Code: MRR-957C47F93E01

The Oxygenator Market is projected to grow by USD 5.76 billion at a CAGR of 10.91% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.51 billion
Estimated Year [2025] USD 2.78 billion
Forecast Year [2032] USD 5.76 billion
CAGR (%) 10.91%

Foundational overview describing clinical importance, design evolution, regulatory dynamics and strategic implications of oxygenator technologies for healthcare leaders

Oxygenators occupy a central role in modern cardiopulmonary and extracorporeal care, enabling clinicians to manage gas exchange during complex procedures and critical care scenarios. This introduction frames the technology's clinical utility, highlights the engineering rationale behind predominant device families, and situates oxygenators within evolving care pathways where patient safety, throughput efficiency, and biocompatibility remain paramount. It further outlines the interplay between device design and procedural needs, showing how incremental improvements in materials, flow dynamics, and surface treatments have translated into practical gains in clinical performance.

As clinical demands diversify across adult, pediatric, and neonatal care, the oxygenator's functional envelope has expanded to accommodate distinct hemodynamic and blood management requirements. Concurrently, regulatory expectations and procurement priorities have shifted to prioritize lifecycle management, post-market surveillance, and demonstrable risk mitigation. In this context, stakeholders must balance operational reliability with adaptability to different care settings, from ambulatory centers and specialty clinics to high-acuity cardiac centers in hospitals.

This section sets the stage for a deeper analysis by emphasizing the converging pressures of clinical evidence, technology innovation, and system-level procurement imperatives that shape product development and adoption. It establishes the foundation for subsequent sections that examine landscape shifts, tariff impacts, segmentation intelligence, regional dynamics, corporate strategies, and actionable recommendations for clinical and commercial leaders.

Emerging technological refinements, clinical practice expansions and regulatory expectations converging to redefine oxygenator design adoption and competitive dynamics

The oxygenator landscape is undergoing transformative shifts driven by technological refinement, changing clinical protocols, and a stronger emphasis on integrated system performance. Advances in membrane chemistry and fiber architectures have improved gas exchange efficiency and blood compatibility, while innovations in sensor integration and control algorithms are enabling more precise management of flow and oxygenation parameters. These technical developments are accompanied by a move toward modularity and disposability considerations that align device lifecycle decisions with infection control priorities and operational cost transparency.

Parallel to technical progress, clinical practice patterns are adapting. There is increased adoption of extracorporeal techniques beyond traditional cardiac surgery, extending into critical care applications and neonatal interventions. As a result, device form factors and performance envelopes are being optimized for a wider array of clinical scenarios. This trend is reinforced by procurement stakeholders seeking devices that can demonstrate ease of use, clear maintenance pathways, and compatibility with existing circuit components.

Regulatory and payer landscapes are also influencing product roadmaps. Greater scrutiny on biocompatibility data, post-market surveillance, and human factors engineering is prompting manufacturers to invest in robust evidence generation. At the same time, strategic partnerships between device makers and clinical centers of excellence are accelerating iterative design and validation, producing offerings that better reflect frontline clinical needs. Taken together, these shifts are reshaping competitive dynamics and raising the bar for sustained clinical adoption.

Anticipatory analysis of how recent United States tariff measures are reshaping supply chains commercial strategies and procurement behaviors in the oxygenator ecosystem

The introduction of new tariff measures in the United States introduces a complex set of operational and strategic effects across the oxygenator value chain that stakeholders must anticipate and manage. Changes to import duties and related trade policies create upstream cost pressures for suppliers that source materials or finished goods internationally. In response, procurement teams and manufacturers reassess sourcing strategies, contract terms, and inventory management practices to preserve margin and continuity of supply amid increased landed costs.

These trade dynamics also influence decisions around regional manufacturing footprints and nearshoring. Organizations that can localize critical production steps or secure domestic supply partnerships gain resilience against tariff volatility, while those that remain dependent on cross-border supply may encounter margin compression or the need to redesign commercial models. Clinical providers facing higher equipment or consumable prices may prioritize devices that demonstrate clear clinical and operational value, prompting manufacturers to strengthen evidence packages and lifecycle cost analyses.

In addition, tariffs can accelerate consolidation and strategic realignment as firms evaluate M&A, licensing, or joint-venture opportunities to mitigate tariff exposure and access local channels. Importantly, suppliers that proactively engage with distributors and institutional customers to redesign commercial terms, establish hedging strategies, or offer bundled service propositions will be better positioned to navigate the transitional period. Overall, tariff shifts act as a catalyst for supply chain optimization, pricing strategy reassessment, and a renewed focus on local operational agility.

In-depth segmentation intelligence connecting product families, control architectures, flow profiles, clinical applications, end users and sales channel dynamics into actionable device strategies

Understanding the oxygenator market requires granular attention to product, technology, flow characteristics, application settings, end users, and sales channel behaviors, because each segmentation axis shapes design priorities and go-to-market approaches. Product classifications-such as Bubble, Hollow Fiber, and Membrane designs-carry distinct clinical and engineering trade-offs; Bubble variants are typically differentiated by High Efficiency and Standard options, Hollow Fiber formats are deployed in Disposable and Reusable iterations, and Membrane systems are tailored with Heparin Coated and Non Coated surface treatments to address biocompatibility concerns. These product distinctions directly inform clinical selection criteria and inventory policies.

Technology choices further refine value propositions: Automatic Control systems offer precision through Electronic Sensors or Pneumatic Sensors, Hybrid platforms combine Semi Automated and Semi Manual capabilities for flexible workflows, and Manual units remain relevant where Foot Operated or Hand Operated simplicity and robustness are prioritized. Flow rate segmentation influences device sizing and performance expectations, with High Flow solutions including High Performance Flow and Ultra High Flow variants, Medium Flow devices presenting Enhanced Flow and Standard Flow profiles, and Low Flow devices addressing Micro Flow and Mini Flow requirements for specialized patient cohorts.

Application contexts-ranging from Cardiopulmonary Bypass with Adult and Pediatric subdivisions, to Extracorporeal Membrane Oxygenation covering Adult and Neonatal uses, and Neonatal Care focused on Incubator Support and Transport Ventilation-dictate clinical feature sets and regulatory considerations. End users span Ambulatory Care Centers, Hospitals, and Specialty Clinics, each including more specific facility types such as Diagnostic Centers and Outpatient Clinics, Cardiac Centers and General Hospitals, and Cardiac Specialty Clinics and Respiratory Specialty Clinics. Finally, sales channel dynamics between Direct strategies-encompassing Institutional Sales and OEM Contracts-Distributor networks divided into National Distributors and Regional Distributors, and Online avenues via Company Website and Third Party Platforms determine how manufacturers allocate resources across customer engagement, training, and post-sale support. Taken together, these segmentation layers create a multidimensional view of demand drivers and competitive differentiation across the oxygenator landscape.

Comparative regional assessment highlighting distinct adoption drivers, regulatory nuances and supply chain priorities across Americas, Europe Middle East & Africa and Asia-Pacific

Regional dynamics exhibit distinct demand drivers, regulatory environments, and supply chain considerations that shape strategic priorities for manufacturers and providers. In the Americas, clinical adoption is influenced by an emphasis on advanced cardiothoracic programs, high-acuity cardiac centers, and integrated hospital systems that value proven clinical outcomes and service reliability. Procurement cycles in this region often prioritize long-term service agreements and interoperability with established extracorporeal circuits, creating opportunities for differentiated support offerings and integrated training programs.

In contrast, Europe, Middle East & Africa encompasses a broad regulatory and healthcare delivery spectrum, where national reimbursement frameworks, regional purchasing consortia, and a growing emphasis on standardization drive device selection. This region places a premium on harmonized safety data, adaptability to both tertiary and community care settings, and scalable service models that can address diverse clinical environments from advanced cardiac centers to emergent care facilities. Manufacturers that demonstrate regulatory alignment and flexible commercial models will find pathways to broader penetration across this heterogeneous territory.

Asia-Pacific presents a mix of rapid clinical capacity expansion, investments in neonatal and critical care infrastructure, and an increasing focus on local manufacturing capabilities. Growing clinical volumes, particularly in tertiary hospitals and specialty clinics, create strong demand for devices that balance cost-effectiveness with clinical performance. Consequently, strategic partnerships, localized service networks, and targeted training initiatives are critical to building trust and ensuring adoption across a wide array of healthcare delivery contexts in this dynamic region.

Strategic company behaviors emphasizing product differentiation, evidence partnerships, supply chain resilience and integrated service offerings as pathways to sustained competitive advantage

Competitive behavior among leading oxygenator manufacturers is shaped by a combination of product innovation, evidence generation, regulatory strategy, and commercial ecosystem development. Successful firms prioritize differentiated device characteristics such as advanced membrane materials, integrated sensor and control systems, and surface treatments that reduce clotting and inflammatory responses. They also invest in clinical partnerships to generate robust real-world evidence and human factors validation, enabling clearer demonstrations of clinical benefit and operational value to procurement stakeholders.

Strategically, top companies balance organic product development with selective external collaborations and licensing arrangements that accelerate time to market while preserving core intellectual property. Supply chain resilience features prominently in corporate planning, with manufacturing redundancy, quality assurance frameworks, and localized assembly or component sourcing used to reduce exposure to trade shifts and logistics disruption. Commercially, firms increasingly bundle devices with training, maintenance, and data-driven service offerings to move beyond transactional sales toward longer-term customer relationships.

Market leaders also cultivate distribution networks that align with end-user needs, leveraging direct institutional engagement where clinical complexity is high, and partnering with national or regional distributors to reach broader ambulatory and clinic markets. Online channels complement traditional approaches by expanding visibility and simplifying ordering for standardized consumables or disposables. These strategic choices collectively inform competitive positioning and capacity to capture opportunities across clinical and geographic segments.

Actionable strategic priorities for manufacturers and providers to align product innovation, evidence generation, supply resilience and tailored commercial models for sustainable adoption

Industry leaders should adopt a set of focused actions that align product development, commercial strategy, and operational resilience to secure long-term growth in oxygenator markets. First, prioritize modular product architectures and surface treatment innovations that improve biocompatibility and ease clinical adoption across adult, pediatric, and neonatal applications. By designing for interoperability and streamlined clinical workflows, manufacturers can lower adoption friction and strengthen value propositions for hospitals and specialty clinics.

Second, accelerate evidence generation through targeted clinical collaborations that demonstrate not only clinical outcomes but also operational benefits such as reduced circuit changeovers and simplified maintenance. This evidence will be essential to support procurement decisions in environments that increasingly demand lifecycle clarity. Third, reinforce supply chain resilience by diversifying suppliers, exploring localized production for critical components, and establishing contingency inventory strategies that mitigate exposure to trade policy shifts.

Fourth, tailor commercial models to match end-user preferences by combining direct institutional engagement in high-acuity centers with expanded distributor relationships and online channels for standardized offerings. Finally, invest in post-sale support and training programs that reduce clinician variability, improve device uptime, and create defensible service relationships. Collectively, these actions will help organizations translate technical capabilities into sustained clinical adoption and commercial performance.

Transparent methodological approach combining clinician interviews, technical literature synthesis and scenario-based analysis to ensure credible and actionable oxygenator insights

This analysis synthesizes primary and secondary qualitative research, structured expert interviews, and a systematic review of clinical and regulatory literature to build a comprehensive view of the oxygenator landscape. Primary inputs included discussions with clinicians across cardiothoracic surgery, intensive care, and neonatal medicine to capture frontline device performance requirements, human factors considerations, and procurement drivers. These practitioner perspectives were combined with interviews of product development leaders, distribution partners, and supply chain specialists to map commercial imperatives and manufacturing constraints.

Secondary evidence was compiled from peer-reviewed clinical studies, regulatory filings, and technical white papers that describe device architectures, materials science advancements, and post-market safety findings. Where appropriate, case studies illustrating successful clinical integration and supplier-customer collaboration were analyzed to extract transferable lessons. The synthesis prioritized triangulation across data sources to ensure robust conclusions, and findings were validated iteratively with industry experts to refine interpretive accuracy.

Analytical methods included thematic coding of qualitative interviews, comparative feature analysis across device architectures and control systems, and scenario-based assessment of supply chain and tariff impacts. Emphasis was placed on transparent assumptions, reproducible analytic logic, and a conservative interpretation of evidence where data gaps exist. This methodical approach supports credible, actionable insights for clinical leaders, procurement teams, and technology developers.

Synthesis of strategic implications underscoring the need for technical excellence, evidence generation and supply resilience to drive clinical adoption and long-term value

In conclusion, oxygenator technologies are at an inflection point where engineering progress, clinical expansion, and commercial realignment intersect to create meaningful opportunities and challenges. Device differentiation increasingly hinges on the integration of advanced membrane materials, improved biocompatible surface treatments, and smarter control systems that together enhance clinical usability and patient safety. Meanwhile, the widening set of clinical applications-from cardiopulmonary bypass across age groups to extracorporeal support and neonatal transport-demands adaptable form factors and evidence-backed performance.

Commercially, supply chain resilience and flexible sales models are becoming as critical as product capability. Tariff-driven cost pressures and regional procurement preferences underscore the need for localized strategies and partnerships that secure supply continuity while maintaining competitive pricing. Providers and manufacturers that combine robust clinical evidence with seamless support and training will be best positioned to drive adoption across diverse care settings.

Ultimately, the oxygenator market rewards organizations that balance technical excellence with operational pragmatism and proactive engagement with clinical stakeholders. Those that execute on innovation, evidence generation, and resilient commercial strategies will capture the greatest long-term value and contribute meaningfully to improved patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of portable extracorporeal oxygenators for emergency responses
  • 5.2. Regulatory push for enhanced biocompatible coatings on membrane oxygenators to reduce hemolysis
  • 5.3. Integration of AI-driven flow monitoring systems into ECMO oxygenators for predictive maintenance
  • 5.4. Surge in demand for low-resistance pediatric oxygenators to improve neonatal cardiac surgery outcomes
  • 5.5. Development of hybrid perfusion platforms combining oxygenators with hemofiltration functions
  • 5.6. Growing interest in polymer-based disposable oxygenators to minimize infection transmission risks

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Oxygenator Market, by Product Type

  • 8.1. Bubble
    • 8.1.1. High Efficiency
    • 8.1.2. Standard
  • 8.2. Hollow Fiber
    • 8.2.1. Disposable
    • 8.2.2. Reusable
  • 8.3. Membrane
    • 8.3.1. Heparin Coated
    • 8.3.2. Non Coated

9. Oxygenator Market, by Technology

  • 9.1. Automatic Control
    • 9.1.1. Electronic Sensors
    • 9.1.2. Pneumatic Sensors
  • 9.2. Hybrid
    • 9.2.1. Semi Automated
    • 9.2.2. Semi Manual
  • 9.3. Manual
    • 9.3.1. Foot Operated
    • 9.3.2. Hand Operated

10. Oxygenator Market, by Flow Rate

  • 10.1. High Flow
    • 10.1.1. High Performance Flow
    • 10.1.2. Ultra High Flow
  • 10.2. Low Flow
    • 10.2.1. Micro Flow
    • 10.2.2. Mini Flow
  • 10.3. Medium Flow
    • 10.3.1. Enhanced Flow
    • 10.3.2. Standard Flow

11. Oxygenator Market, by Application

  • 11.1. Cardiopulmonary Bypass
    • 11.1.1. Adult
    • 11.1.2. Pediatric
  • 11.2. Extracorporeal Membrane Oxygenation
    • 11.2.1. Adult
    • 11.2.2. Neonatal
  • 11.3. Neonatal Care
    • 11.3.1. Incubator Support
    • 11.3.2. Transport Ventilation

12. Oxygenator Market, by End User

  • 12.1. Ambulatory Care Centers
    • 12.1.1. Diagnostic Centers
    • 12.1.2. Outpatient Clinics
  • 12.2. Hospitals
    • 12.2.1. Cardiac Centers
    • 12.2.2. General Hospitals
  • 12.3. Specialty Clinics
    • 12.3.1. Cardiac Specialty Clinics
    • 12.3.2. Respiratory Specialty Clinics

13. Oxygenator Market, by Sales Channel

  • 13.1. Direct
    • 13.1.1. Institutional Sales
    • 13.1.2. Oem Contracts
  • 13.2. Distributor
    • 13.2.1. National Distributors
    • 13.2.2. Regional Distributors
  • 13.3. Online
    • 13.3.1. Company Website
    • 13.3.2. Third Party Platforms

14. Oxygenator Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Oxygenator Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Oxygenator Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Terumo Corporation
    • 17.3.2. Medtronic plc
    • 17.3.3. LivaNova PLC
    • 17.3.4. Getinge AB
    • 17.3.5. Fresenius SE & Co. KGaA
    • 17.3.6. Nipro Corporation
    • 17.3.7. Nikkiso Co., Ltd.
    • 17.3.8. Medos Medizintechnik AG
    • 17.3.9. Asahi Kasei Medical Co., Ltd.
    • 17.3.10. MC3 Group, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL OXYGENATOR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL OXYGENATOR MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL OXYGENATOR MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL OXYGENATOR MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL OXYGENATOR MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL OXYGENATOR MARKET SIZE, BY FLOW RATE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL OXYGENATOR MARKET SIZE, BY FLOW RATE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL OXYGENATOR MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL OXYGENATOR MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL OXYGENATOR MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL OXYGENATOR MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL OXYGENATOR MARKET SIZE, BY SALES CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL OXYGENATOR MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL OXYGENATOR MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS OXYGENATOR MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA OXYGENATOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA OXYGENATOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA OXYGENATOR MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE OXYGENATOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST OXYGENATOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA OXYGENATOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC OXYGENATOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL OXYGENATOR MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN OXYGENATOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC OXYGENATOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION OXYGENATOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS OXYGENATOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 OXYGENATOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO OXYGENATOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL OXYGENATOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. OXYGENATOR MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. OXYGENATOR MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. OXYGENATOR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL OXYGENATOR MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL OXYGENATOR MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL OXYGENATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL OXYGENATOR MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL OXYGENATOR MARKET SIZE, BY BUBBLE, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL OXYGENATOR MARKET SIZE, BY BUBBLE, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL OXYGENATOR MARKET SIZE, BY BUBBLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL OXYGENATOR MARKET SIZE, BY BUBBLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL OXYGENATOR MARKET SIZE, BY BUBBLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL OXYGENATOR MARKET SIZE, BY BUBBLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL OXYGENATOR MARKET SIZE, BY BUBBLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL OXYGENATOR MARKET SIZE, BY BUBBLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL OXYGENATOR MARKET SIZE, BY HIGH EFFICIENCY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL OXYGENATOR MARKET SIZE, BY HIGH EFFICIENCY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL OXYGENATOR MARKET SIZE, BY HIGH EFFICIENCY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL OXYGENATOR MARKET SIZE, BY HIGH EFFICIENCY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL OXYGENATOR MARKET SIZE, BY HIGH EFFICIENCY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL OXYGENATOR MARKET SIZE, BY HIGH EFFICIENCY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL OXYGENATOR MARKET SIZE, BY STANDARD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL OXYGENATOR MARKET SIZE, BY STANDARD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL OXYGENATOR MARKET SIZE, BY STANDARD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL OXYGENATOR MARKET SIZE, BY STANDARD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL OXYGENATOR MARKET SIZE, BY STANDARD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL OXYGENATOR MARKET SIZE, BY STANDARD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL OXYGENATOR MARKET SIZE, BY HOLLOW FIBER, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL OXYGENATOR MARKET SIZE, BY HOLLOW FIBER, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL OXYGENATOR MARKET SIZE, BY HOLLOW FIBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL OXYGENATOR MARKET SIZE, BY HOLLOW FIBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL OXYGENATOR MARKET SIZE, BY HOLLOW FIBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL OXYGENATOR MARKET SIZE, BY HOLLOW FIBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL OXYGENATOR MARKET SIZE, BY HOLLOW FIBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL OXYGENATOR MARKET SIZE, BY HOLLOW FIBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL OXYGENATOR MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL OXYGENATOR MARKET SIZE, BY DISPOSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL OXYGENATOR MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL OXYGENATOR MARKET SIZE, BY DISPOSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL OXYGENATOR MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL OXYGENATOR MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL OXYGENATOR MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL OXYGENATOR MARKET SIZE, BY REUSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL OXYGENATOR MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL OXYGENATOR MARKET SIZE, BY REUSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL OXYGENATOR MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL OXYGENATOR MARKET SIZE, BY REUSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL OXYGENATOR MARKET SIZE, BY MEMBRANE, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL OXYGENATOR MARKET SIZE, BY MEMBRANE, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL OXYGENATOR MARKET SIZE, BY MEMBRANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL OXYGENATOR MARKET SIZE, BY MEMBRANE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL OXYGENATOR MARKET SIZE, BY MEMBRANE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL OXYGENATOR MARKET SIZE, BY MEMBRANE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL OXYGENATOR MARKET SIZE, BY MEMBRANE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL OXYGENATOR MARKET SIZE, BY MEMBRANE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL OXYGENATOR MARKET SIZE, BY HEPARIN COATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL OXYGENATOR MARKET SIZE, BY HEPARIN COATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL OXYGENATOR MARKET SIZE, BY HEPARIN COATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL OXYGENATOR MARKET SIZE, BY HEPARIN COATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL OXYGENATOR MARKET SIZE, BY HEPARIN COATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL OXYGENATOR MARKET SIZE, BY HEPARIN COATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL OXYGENATOR MARKET SIZE, BY NON COATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL OXYGENATOR MARKET SIZE, BY NON COATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL OXYGENATOR MARKET SIZE, BY NON COATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL OXYGENATOR MARKET SIZE, BY NON COATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL OXYGENATOR MARKET SIZE, BY NON COATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL OXYGENATOR MARKET SIZE, BY NON COATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL OXYGENATOR MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL OXYGENATOR MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL OXYGENATOR MARKET SIZE, BY AUTOMATIC CONTROL, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL OXYGENATOR MARKET SIZE, BY AUTOMATIC CONTROL, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL OXYGENATOR MARKET SIZE, BY AUTOMATIC CONTROL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL OXYGENATOR MARKET SIZE, BY AUTOMATIC CONTROL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL OXYGENATOR MARKET SIZE, BY AUTOMATIC CONTROL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL OXYGENATOR MARKET SIZE, BY AUTOMATIC CONTROL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL OXYGENATOR MARKET SIZE, BY AUTOMATIC CONTROL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL OXYGENATOR MARKET SIZE, BY AUTOMATIC CONTROL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL OXYGENATOR MARKET SIZE, BY ELECTRONIC SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL OXYGENATOR MARKET SIZE, BY ELECTRONIC SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL OXYGENATOR MARKET SIZE, BY ELECTRONIC SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL OXYGENATOR MARKET SIZE, BY ELECTRONIC SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL OXYGENATOR MARKET SIZE, BY ELECTRONIC SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL OXYGENATOR MARKET SIZE, BY ELECTRONIC SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL OXYGENATOR MARKET SIZE, BY PNEUMATIC SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL OXYGENATOR MARKET SIZE, BY PNEUMATIC SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL OXYGENATOR MARKET SIZE, BY PNEUMATIC SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL OXYGENATOR MARKET SIZE, BY PNEUMATIC SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL OXYGENATOR MARKET SIZE, BY PNEUMATIC SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL OXYGENATOR MARKET SIZE, BY PNEUMATIC SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL OXYGENATOR MARKET SIZE, BY HYBRID, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL OXYGENATOR MARKET SIZE, BY HYBRID, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL OXYGENATOR MARKET SIZE, BY HYBRID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL OXYGENATOR MARKET SIZE, BY HYBRID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL OXYGENATOR MARKET SIZE, BY HYBRID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL OXYGENATOR MARKET SIZE, BY HYBRID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL OXYGENATOR MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL OXYGENATOR MARKET SIZE, BY HYBRID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL OXYGENATOR MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL OXYGENATOR MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL OXYGENATOR MARKET SIZE, BY SEMI AUTOMATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL OXYGENATOR MARKET SIZE, BY SEMI AUTOMATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL OXYGENATOR MARKET SIZE, BY SEMI AUTOMATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL OXYGENATOR MARKET SIZE, BY SEMI AUTOMATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL OXYGENATOR MARKET SIZE, BY SEMI MANUAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL OXYGENATOR MARKET SIZE, BY SEMI MANUAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL OXYGENATOR MARKET SIZE, BY SEMI MANUAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL OXYGENATOR MARKET SIZE, BY SEMI MANUAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL OXYGENATOR MARKET SIZE, BY SEMI MANUAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL OXYGENATOR MARKET SIZE, BY SEMI MANUAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL OXYGENATOR MARKET SIZE, BY MANUAL, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL OXYGENATOR MARKET SIZE, BY MANUAL, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL OXYGENATOR MARKET SIZE, BY MANUAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL OXYGENATOR MARKET SIZE, BY MANUAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL OXYGENATOR MARKET SIZE, BY MANUAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL OXYGENATOR MARKET SIZE, BY MANUAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL OXYGENATOR MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL OXYGENATOR MARKET SIZE, BY MANUAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL OXYGENATOR MARKET SIZE, BY FOOT OPERATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL OXYGENATOR MARKET SIZE, BY FOOT OPERATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL OXYGENATOR MARKET SIZE, BY FOOT OPERATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL OXYGENATOR MARKET SIZE, BY FOOT OPERATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL OXYGENATOR MARKET SIZE, BY FOOT OPERATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL OXYGENATOR MARKET SIZE, BY FOOT OPERATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL OXYGENATOR MARKET SIZE, BY HAND OPERATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL OXYGENATOR MARKET SIZE, BY HAND OPERATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL OXYGENATOR MARKET SIZE, BY HAND OPERATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL OXYGENATOR MARKET SIZE, BY HAND OPERATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL OXYGENATOR MARKET SIZE, BY HAND OPERATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL OXYGENATOR MARKET SIZE, BY HAND OPERATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL OXYGENATOR MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL OXYGENATOR MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL OXYGENATOR MARKET SIZE, BY HIGH FLOW, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL OXYGENATOR MARKET SIZE, BY HIGH FLOW, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL OXYGENATOR MARKET SIZE, BY HIGH FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL OXYGENATOR MARKET SIZE, BY HIGH FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL OXYGENATOR MARKET SIZE, BY HIGH FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL OXYGENATOR MARKET SIZE, BY HIGH FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL OXYGENATOR MARKET SIZE, BY HIGH FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL OXYGENATOR MARKET SIZE, BY HIGH FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL OXYGENATOR MARKET SIZE, BY HIGH PERFORMANCE FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL OXYGENATOR MARKET SIZE, BY HIGH PERFORMANCE FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL OXYGENATOR MARKET SIZE, BY HIGH PERFORMANCE FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL OXYGENATOR MARKET SIZE, BY HIGH PERFORMANCE FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL OXYGENATOR MARKET SIZE, BY HIGH PERFORMANCE FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL OXYGENATOR MARKET SIZE, BY HIGH PERFORMANCE FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL OXYGENATOR MARKET SIZE, BY ULTRA HIGH FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL OXYGENATOR MARKET SIZE, BY ULTRA HIGH FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL OXYGENATOR MARKET SIZE, BY ULTRA HIGH FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL OXYGENATOR MARKET SIZE, BY ULTRA HIGH FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL OXYGENATOR MARKET SIZE, BY ULTRA HIGH FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL OXYGENATOR MARKET SIZE, BY ULTRA HIGH FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL OXYGENATOR MARKET SIZE, BY LOW FLOW, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL OXYGENATOR MARKET SIZE, BY LOW FLOW, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL OXYGENATOR MARKET SIZE, BY LOW FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL OXYGENATOR MARKET SIZE, BY LOW FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL OXYGENATOR MARKET SIZE, BY LOW FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL OXYGENATOR MARKET SIZE, BY LOW FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL OXYGENATOR MARKET SIZE, BY LOW FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL OXYGENATOR MARKET SIZE, BY LOW FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL OXYGENATOR MARKET SIZE, BY MICRO FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL OXYGENATOR MARKET SIZE, BY MICRO FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL OXYGENATOR MARKET SIZE, BY MICRO FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL OXYGENATOR MARKET SIZE, BY MICRO FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL OXYGENATOR MARKET SIZE, BY MICRO FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL OXYGENATOR MARKET SIZE, BY MICRO FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL OXYGENATOR MARKET SIZE, BY MINI FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL OXYGENATOR MARKET SIZE, BY MINI FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL OXYGENATOR MARKET SIZE, BY MINI FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL OXYGENATOR MARKET SIZE, BY MINI FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL OXYGENATOR MARKET SIZE, BY MINI FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL OXYGENATOR MARKET SIZE, BY MINI FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL OXYGENATOR MARKET SIZE, BY MEDIUM FLOW, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL OXYGENATOR MARKET SIZE, BY MEDIUM FLOW, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL OXYGENATOR MARKET SIZE, BY MEDIUM FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL OXYGENATOR MARKET SIZE, BY MEDIUM FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL OXYGENATOR MARKET SIZE, BY MEDIUM FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL OXYGENATOR MARKET SIZE, BY MEDIUM FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL OXYGENATOR MARKET SIZE, BY MEDIUM FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL OXYGENATOR MARKET SIZE, BY MEDIUM FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL OXYGENATOR MARKET SIZE, BY ENHANCED FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL OXYGENATOR MARKET SIZE, BY ENHANCED FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL OXYGENATOR MARKET SIZE, BY ENHANCED FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL OXYGENATOR MARKET SIZE, BY ENHANCED FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL OXYGENATOR MARKET SIZE, BY ENHANCED FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL OXYGENATOR MARKET SIZE, BY ENHANCED FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL OXYGENATOR MARKET SIZE, BY STANDARD FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL OXYGENATOR MARKET SIZE, BY STANDARD FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL OXYGENATOR MARKET SIZE, BY STANDARD FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL OXYGENATOR MARKET SIZE, BY STANDARD FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL OXYGENATOR MARKET SIZE, BY STANDARD FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL OXYGENATOR MARKET SIZE, BY STANDARD FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL OXYGENATOR MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL OXYGENATOR MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL OXYGENATOR MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL OXYGENATOR MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL OXYGENATOR MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL OXYGENATOR MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL OXYGENATOR MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL OXYGENATOR MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL OXYGENATOR MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL OXYGENATOR MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL OXYGENATOR MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL OXYGENATOR MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL OXYGENATOR MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL OXYGENATOR MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL OXYGENATOR MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL OXYGENATOR MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL OXYGENATOR MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL OXYGENATOR MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL OXYGENATOR MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL OXYGENATOR MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL OXYGENATOR MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL OXYGENATOR MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL OXYGENATOR MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL OXYGENATOR MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL OXYGENATOR MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL OXYGENATOR MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL OXYGENATOR MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL OXYGENATOR MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL OXYGENATOR MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL OXYGENATOR MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL OXYGENATOR MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL OXYGENATOR MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL OXYGENATOR MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL OXYGENATOR MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL OXYGENATOR MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL OXYGENATOR MARKET SIZE, BY NEONATAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL OXYGENATOR MARKET SIZE, BY NEONATAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL OXYGENATOR MARKET SIZE, BY NEONATAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL OXYGENATOR MARKET SIZE, BY NEONATAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL OXYGENATOR MARKET SIZE, BY NEONATAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL OXYGENATOR MARKET SIZE, BY NEONATAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL OXYGENATOR MARKET SIZE, BY NEONATAL CARE, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL OXYGENATOR MARKET SIZE, BY NEONATAL CARE, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL OXYGENATOR MARKET SIZE, BY NEONATAL CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL OXYGENATOR MARKET SIZE, BY NEONATAL CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL OXYGENATOR MARKET SIZE, BY NEONATAL CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL OXYGENATOR MARKET SIZE, BY NEONATAL CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL OXYGENATOR MARKET SIZE, BY NEONATAL CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL OXYGENATOR MARKET SIZE, BY NEONATAL CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL OXYGENATOR MARKET SIZE, BY INCUBATOR SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL OXYGENATOR MARKET SIZE, BY INCUBATOR SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL OXYGENATOR MARKET SIZE, BY INCUBATOR SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL OXYGENATOR MARKET SIZE, BY INCUBATOR SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL OXYGENATOR MARKET SIZE, BY INCUBATOR SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL OXYGENATOR MARKET SIZE, BY INCUBATOR SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL OXYGENATOR MARKET SIZE, BY TRANSPORT VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL OXYGENATOR MARKET SIZE, BY TRANSPORT VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL OXYGENATOR MARKET SIZE, BY TRANSPORT VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL OXYGENATOR MARKET SIZE, BY TRANSPORT VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL OXYGENATOR MARKET SIZE, BY TRANSPORT VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL OXYGENATOR MARKET SIZE, BY TRANSPORT VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL OXYGENATOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL OXYGENATOR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL OXYGENATOR MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL OXYGENATOR MARKET SIZE, BY AMBULATORY CARE CENTERS, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL OXYGENATOR MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL OXYGENATOR MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL OXYGENATOR MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL OXYGENATOR MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL OXYGENATOR MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL OXYGENATOR MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL OXYGENATOR MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL OXYGENATOR MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL OXYGENATOR MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL OXYGENATOR MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL OXYGENATOR MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL OXYGENATOR MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL OXYGENATOR MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL OXYGENATOR MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL OXYGENATOR MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL OXYGENATOR MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL OXYGENATOR MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL OXYGENATOR MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL OXYGENATOR MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL OXYGENATOR MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL OXYGENATOR MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL OXYGENATOR MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL OXYGENATOR MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL OXYGENATOR MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL OXYGENATOR MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL OXYGENATOR MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL OXYGENATOR MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL OXYGENATOR MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL OXYGENATOR MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL OXYGENATOR MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL OXYGENATOR MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL OXYGENATOR MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL OXYGENATOR MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL OXYGENATOR MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL OXYGENATOR MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL OXYGENATOR MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL OXYGENATOR MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL OXYGENATOR MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL OXYGENATOR MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL OXYGENATOR MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL OXYGENATOR MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL OXYGENATOR MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL OXYGENATOR MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL OXYGENATOR MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL OXYGENATOR MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL OXYGENATOR MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. GLOBAL OXYGENATOR MARKET SIZE, BY CARDIAC SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 304. GLOBAL OXYGENATOR MARKET SIZE, BY CARDIAC SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL OXYGENATOR MARKET SIZE, BY CARDIAC SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL OXYGENATOR MARKET SIZE, BY CARDIAC SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 307. GLOBAL OXYGENATOR MARKET SIZE, BY CARDIAC SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. GLOBAL OXYGENATOR MARKET SIZE, BY CARDIAC SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. GLOBAL OXYGENATOR MARKET SIZE, BY RESPIRATORY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 310. GLOBAL OXYGENATOR MARKET SIZE, BY RESPIRATORY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL OXYGENATOR MARKET SIZE, BY RESPIRATORY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL OXYGENATOR MARKET SIZE, BY RESPIRATORY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 313. GLOBAL OXYGENATOR MARKET SIZE, BY RESPIRATORY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. GLOBAL OXYGENATOR MARKET SIZE, BY RESPIRATORY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. GLOBAL OXYGENATOR MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 316. GLOBAL OXYGENATOR MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 317. GLOBAL OXYGENATOR MARKET SIZE, BY DIRECT, 2018-2024 (USD MILLION)
  • TABLE 318. GLOBAL OXYGENATOR MARKET SIZE, BY DIRECT, 2025-2032 (USD MILLION)
  • TABLE 319. GLOBAL OXYGENATOR MARKET SIZE, BY DIRECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 320. GLOBAL OXYGENATOR MARKET SIZE, BY DIRECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 321. GLOBAL OXYGENATOR MARKET SIZE, BY DIRECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 322. GLOBAL OXYGENATOR MARKET SIZE, BY DIRECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 323. GLOBAL OXYGENATOR MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 324. GLOBAL OXYGENATOR MARKET SIZE, BY DIRECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 325. GLOBAL OXYGENATOR MARKET SIZE, BY INSTITUTIONAL SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 326. GLOBAL OXYGENATOR MARKET SIZE, BY INSTITUTIONAL SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 327. GLOBAL OXYGENATOR MARKET SIZE, BY INSTITUTIONAL SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 328. GLOBAL OXYGENATOR MARKET SIZE, BY INSTITUTIONAL SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 329. GLOBAL OXYGENATOR MARKET SIZE, BY INSTITUTIONAL SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 330. GLOBAL OXYGENATOR MARKET SIZE, BY INSTITUTIONAL SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 331. GLOBAL OXYGENATOR MARKET SIZE, BY OEM CONTRACTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 332. GLOBAL OXYGENATOR MARKET SIZE, BY OEM CONTRACTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 333. GLOBAL OXYGENATOR MARKET SIZE, BY OEM CONTRACTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 334. GLOBAL OXYGENATOR MARKET SIZE, BY OEM CONTRACTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 335. GLOBAL OXYGENATOR MARKET SIZE, BY OEM CONTRACTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 336. GLOBAL OXYGENATOR MARKET SIZE, BY OEM CONTRACTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 337. GLOBAL OXYGENATOR MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 338. GLOBAL OXYGENATOR MARKET SIZE, BY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 339. GLOBAL OXYGENATOR MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 340. GLOBAL OXYGENATOR MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 341. GLOBAL OXYGENATOR MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 342. GLOBAL OXYGENATOR MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 343. GLOBAL OXYGENATOR MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 344. GLOBAL OXYGENATOR MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 345. GLOBAL OXYGENATOR MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 346. GLOBAL OXYGENATOR MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 347. GLOBAL OXYGENATOR MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 348. GLOBAL OXYGENATOR MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 349. GLOBAL OXYGENATOR MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 350. GLOBAL OXYGENATOR MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 351. GLOBAL OXYGENATOR MARKET SIZE, BY REGIONAL D